113102-01-5

Upstream product

• 117942-41-3 4-[(2-methoxyethoxy)methoxy]benzaldehyde 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 1345676-74-5 C₃₇H₅₆N₆O₁₀S 
• 928821-35-6 tokaramide A 
• 1345676-75-6 C₂₃H₃₄N₆O₄ 
• 1345676-76-7 C₂₅H₄₁N₇O₆ 
• 1345676-72-3 (MEM)HBA-Val-Val-Arg(Mtr)-N(OMe)Me 
• 1271521-43-7 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-[4-(2-methoxyethoxymethoxy)benzoylamino]propanoate 
• 1271521-46-0 (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-(4-methoxybenzoylamino)propanoic acid 
• 1271521-45-9 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-(4-methoxybenzoylamino)propanoate 
• 1271521-44-8 methyl (S)-3-(4-hydroxybenzoylamino)-2-(4-methanesulphonylpiperazin-1-yl)propanoate 
• 1271521-78-8 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-[4-(pyridin-4-ylmethoxy)benzoylamino]propanoate 

Relevant academic research and scientific papers

Synthesis of tokaramide A, a cysteine protease inhibitor from marine sponge Theonella aff. mirabilis

The first synthesis of tokaramide A (1) is described. Tokaramide A (1) was synthesized via the peptide with a side-chain unprotected arginine residue on Weinreb AM resin by reductive cleavage.

N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS

The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I), and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.

4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES

The present invention relates to novel benzene- carboxamide compounds having a structure that corresponds to the general formula (I) below: and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or